Roche purchased similar capabilities for $200M - Bloodhound. Our ‘Puppy’ has been vetted by a global leader and the first right of refusal has been purchased.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free